Second, the solid subcutaneous tumor xenograft model used in this study was a different tumor environment from that of human acute lymphocytic leukemia of the blood, for which CD19-CAR T-cells have been shown to have a dramatic therapeutic effect. The gene discussed is CD19; the disease is neoplasm.